CoChat
Sign Up
Cited by 115

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism

Aregger, Michael, Lawson, Keith A., Billmann, Maximillian, Costanzo, Michael, Tong, Amy H. Y., Chan, Katherine, Rahman, Mahfuzur, Brown, Kevin R., Ross, Catherine, Usaj, Matej, Nedyalkova, Lucy, Sizova, Olga, Habsid, Andrea, Pawling, Judy, Lin, Zhen-Yuan, Abdouni, Hala, Wong, Cassandra J., Weiss, Alexander, Mero, Patricia, Dennis, James W., Gingras, Anne-Claude, Myers, Chad L., Andrews, Brenda J., Boone, Charles, Moffat, Jason·2020·Nature Metabolism
DOI 10.1038/s42255-020-0211-zPMC PMC7566881

Published version of a preprint

Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42255-020-0211-z

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 56

  1. Chen, M. & Huang, J. The expanded role of fatty acid metabolism in cancer: new aspects and targets. Precis. Clin. Med 2, 183–191 (2019). · DOI
  2. Chen, R. R. et al. Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells. Commun. Biol 2, 281 (2019). · DOI
  3. Imoto, M. Chemistry and biology for the small molecules targeting characteristics of cancer cells. Biosci. Biotechnol. Biochem. 83, 1–10 (2018).
  4. Menendez, J. A. & Lupu, R. Fatty acid synthase (FASN) as a therapeutic target in breast cancer. Expert Opin. Ther. Targets 21, 1001–1016 (2017). · DOI
  5. Garber, K. Cancer anabolic metabolism inhibitors move into clinic. Nat. Biotechnol. 34, 794–795 (2016). · DOI
  6. Röhrig, F. & Schulze, A. The multifaceted roles of fatty acid synthesis in cancer. Nat. Rev. Cancer 16, 732–749 (2016). · DOI · Paper page
  7. Jones, S. F. & Infante, J. R. Molecular pathways: fatty acid synthase. Clin. Cancer Res. 21, 5434–5438 (2015). · DOI
  8. Benjamin, D. I. et al. Diacylglycerol metabolism and signaling is a driving force underlying FASN inhibitor sensitivity in cancer cells. ACS Chem. Biol. 10, 1616–1623 (2015). · DOI
  9. Birsoy, K. et al. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162, 540–551 (2015). · DOI · Paper page
  10. Fischer, B. et al. A map of directional genetic interactions in a metazoan cell. eLife 4, e05464 (2015). · DOI
  11. Harrison, R., Papp, B., Pál, C., Oliver, S. G. & Delneri, D. Plasticity of genetic interactions in metabolic networks of yeast. Proc. Natl Acad. Sci. USA 104, 2307–2312 (2007). · DOI
  12. Szappanos, B. et al. An integrated approach to characterize genetic interaction networks in yeast metabolism. Nat. Genet. 43, 656–662 (2011). · DOI
  13. Wright, A. V., Nuñez, J. K. & Doudna, J. A. Biology and applications of CRISPR systems: harnessing nature’s toolbox for genome engineering. Cell 164, 29–44 (2016). · DOI · Paper page
  14. Doench, J. G. Am I ready for CRISPR? A user’s guide to genetic screens. Nat. Rev. Genet. 19, 67–80 (2018). · DOI · Paper page
  15. Carette, J. E. et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477, 340–343 (2011). · DOI
  16. Billmann, M., Chaudhary, V., ElMaghraby, M. F., Fischer, B. & Boutros, M. Widespread rewiring of genetic networks upon cancer signaling pathway activation. Cell Syst. 6, 52–64(2018). · DOI
  17. Ryczko, M. C. et al. Metabolic reprogramming by hexosamine biosynthetic and Golgi N-glycan branching pathways. Sci. Rep. 6, 23043 (2016). · DOI
  18. Cheng, C. et al. Glucose-mediated N-glycosylation of SCAP is essential for SREBP-1 activation and tumor growth. Cancer Cell 28, 569–581 (2015). · DOI
  19. Wang, S. et al. Site-specific O-glycosylation of members of the low-density lipoprotein receptor superfamily enhances ligand interactions. J. Biol. Chem. 293, 7408–7422 (2018). · DOI
  20. Obaidat, A., Roth, M. & Hagenbuch, B. The expression and function of organic anion transporting polypeptides in normal tissues and in cancer. Annu. Rev. Pharmacol. Toxicol. 52, 135–151 (2012). · DOI
  21. Romero, P. et al. Computational prediction of human metabolic pathways from the complete human genome. Genome Biol. 6, R2 (2005). · DOI
  22. Scott, C. C., Vossio, S., Rougemont, J. & Gruenberg, J. TFAP2 transcription factors are regulators of lipid droplet biogenesis. eLife 7, e36330 (2018). · DOI
  23. Shimano, H. & Sato, R. SREBP-regulated lipid metabolism: convergent physiology — divergent pathophysiology. Nat. Rev. Endocrinol. 13, 710–730 (2017). · DOI · Paper page
  24. Zhou, Z., Zhou, J., Su, Z. & Gu, X. Asymmetric evolution of human transcription factor regulatory networks. Mol. Biol. Evol 31, 2149–2155 (2014). · DOI
  25. Ascencio, D., Ochoa, S., Delaye, L. & DeLuna, A. Increased rates of protein evolution and asymmetric deceleration after the whole-genome duplication in yeasts. BMC Evol. Biol. 17, 40 (2017). · DOI
  26. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 47, D506–D515 (2019). · DOI · Paper page
  27. Mitchell, A. L. et al. InterPro in 2019: improving coverage, classification and access to protein sequence annotations. Nucleic Acids Res. 47, D351–D360 (2019). · DOI · Paper page
  28. Uhlen, M. et al. Tissue-based map of the human proteome. Science 347, 1260419–1260419 (2015). · DOI · Paper page
  29. Nagy, Á., Lánczky, A., Menyhárt, O. & Győrffy, B. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci. Rep. 8, 9227 (2018). · DOI
  30. Meyers, R. M. et al. Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells. Nat. Genet. 49, 1779–1784 (2017). · DOI · Paper page
  31. Klarin, D. et al. Genetics of blood lipids among ~300,000 multi-ethnic participants of the million veteran program. Nat. Genet. 50, 1514–1523 (2018). · DOI · Paper page
  32. Brown, M. S. & Goldstein, J. L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89, 331–340 (1997). · DOI · Paper page
  33. Go, C. D. et al. A proximity biotinylation map of a human cell. Preprint at bioRxiv https://doi.org/10.1101/796391(2019). · DOI
  34. Costanzo, M. et al. Global genetic networks and the genotype-to-phenotype relationship. Cell 177, 85–100 (2019). · DOI · Paper page
  35. Han, K. et al. Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions. Nat. Biotechnol. 35, 463–474 (2017). · DOI
  36. Gonatopoulos-Pournatzis, T. et al. Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9–Cas12a platform. Nat. Biotechnol. 38, 638–648 (2020). · DOI · Paper page
  37. Brenner, A. et al. Heavily pre-treated breast cancer patients show promising responses in the first in human study of the first-In-class fatty acid synthase (FASN) inhibitor, TVB-2640 in combination with paclitaxel. in Cancer Res. 77, abstr. P6-11-09 (2017). · DOI · Paper page
  38. Gimeno, R. E. Fatty acid transport proteins. Curr. Opin. Lipidol. 18, 271–276 (2007). · DOI
  39. Boyle, E. A., Pritchard, J. K. & Greenleaf, W. J. High-resolution mapping of cancer cell networks using co-functional interactions. Mol. Syst. Biol. 14, e8594 (2018). · DOI
  40. Kim, E. et al. A network of human functional gene interactions from knockout fitness screens in cancer cells. Life Sci. Alliance 2, e201800278 (2019). · DOI
  41. Luciano, M. et al. Association analysis in over 329,000 individuals identifies 116 independent variants influencing neuroticism. Nat. Genet. 50, 6–11 (2018). · DOI · Paper page
  42. Kichaev, G. et al. Leveraging polygenic functional enrichment to improve GWAS power. Am. J. Hum. Genet. 104, 65–75 (2019). · DOI · Paper page
  43. Nagel, M., Watanabe, K., Stringer, S., Posthuma, D. & van der Sluis, S. Item-level analyses reveal genetic heterogeneity in neuroticism. Nat. Commun. 9, 905 (2018). · DOI
  44. Aregger, M., Chandrashekhar, M., Tong, A. H. Y., Chan, K. & Moffat, J. Pooled lentiviral CRISPR–Cas9 screens for functional genomics in mammalian cells. Methods Mol. Biol. 1869, 169–188 (2019). · DOI
  45. Hesketh, G. G., Youn, J. Y., Samavarchi-Tehrani, P., Raught, B. & Gingras, A. C. Parallel exploration of interaction space by BioID and affinity purification coupled to mass spectrometry. Methods Mol. Biol 1550, 115–136 (2017). · DOI
  46. Branon, T. C. et al. Efficient proximity labeling in living cells and organisms with TurboID. Nat. Biotechnol. 36, 880–887 (2018). · DOI · Paper page
  47. Knight, J. D. R. et al. ProHits-viz: a suite of web tools for visualizing interaction proteomics data. Nat. Methods 14, 645–646 (2017). · DOI
  48. Liu, G. et al. Data independent acquisition analysis in ProHits 4.0. J. Proteomics 149, 64–68 (2016). · DOI
  49. Deutsch, E. W. et al. Trans-Proteomic pipeline, a standardized data processing pipeline for large-scale reproducible proteomics informatics. Proteomics. Clin. Appl. 9, 745–754 (2015). · DOI · Paper page
  50. Teo, G. et al. SAINTexpress: improvements and additional features in significance analysis of INTeractome software. J. Proteomics 100, 37–43 (2014). · DOI
  51. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013). · DOI · Paper page
  52. Abdel Rahman, A. M., Ryczko, M., Pawling, J. & Dennis, J. W. Probing the hexosamine biosynthetic pathway in human tumor cells by multitargeted tandem mass spectrometry. ACS Chem. Biol. 8, 2053–2062 (2013). · DOI
  53. Hart, T. et al. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163, 1515–1526 (2015). · DOI · Paper page
  54. Greene, C. S. et al. Understanding multicellular function and disease with human tissue-specific networks. Nat. Genet. 47, 569–576 (2015). · DOI · Paper page
  55. Ashburner, M. et al. Gene Ontology: tool for the unification of biology. Nat. Genet. 25, 25–29 (2000). · DOI · Paper page
  56. Raudvere, U. et al. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 47, W191–W198 (2019). · DOI · Paper page

Cited by

Sorted by citations

See all 115

Metadata

Authors
Aregger, M., Lawson, K. A., Billmann, M., Costanzo, M., Tong, A. H. Y., Chan, K., Rahman, M., Brown, K. R., Ross, C., Usaj, M., Nedyalkova, L., Sizova, O., Habsid, A., Pawling, J., Lin, Z.-Y., Abdouni, H., Wong, C. J., Weiss, A., Mero, P., Dennis, J. W., Gingras, A.-C., Myers, C. L., Andrews, B. J., Boone, C., & Moffat, J.
ORCID
Venue
Nature Metabolism
Publisher
Springer Science and Business Media LLC
Published
2020-06-01
Volume
2
Issue
6
Pages
499-513
ISSN
2522-5812
DOI
10.1038/s42255-020-0211-z
PMC
PMC7566881
Cited by
115
References
13
Language
en
Licence
Funders
  • Swiss National Science Foundation | nccr – on the move
  • Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (Vanier)
  • Kidney Cancer Association
  • Kidney Cancer Research Network of Canada
  • Ontario Research Foundation
  • U.S. Department of Health & Human Services | National Institutes of Health (R01HG005084)
  • National Science Foundation (R01HG005084)
  • Gouvernement du Canada | Canadian Institutes of Health Research (MOP-142375)
  • Canada Research Chairs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review